On 2026-07-15, Cannara Biotech Inc. (T.LOV) announced earnings per share of 0.05 for the fiscal quarter ending 2026-05-31, beating the average analyst estimate of 0.03.

The next expected annoucement date for quarterly earnings is 2026-10-21, with an average estimated earnings per share of 0.04 for the fiscal quarter ending 2026-08-31.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.